Earnings Feed
Start Free
Guardant Health, Inc.·4

Apr 2, 5:21 PM ET

EAGLE CRAIG 4

4 · Guardant Health, Inc. · Filed Apr 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Guardant Health CMO Craig Eagle Withholds 5,779 Shares for Taxes

What Happened

  • Craig Eagle, Chief Medical Officer of Guardant Health (GH), had restricted stock units convert into 11,400 shares on April 1, 2026 (four separate vesting installments: 1,714; 1,667; 2,660; 5,359). The company withheld 5,779 of those shares to satisfy tax withholding at a per-share value of $91.15, totaling $526,756. No cash exercise price was paid (conversion of RSUs, not option cash exercise).
  • Net shares delivered to Eagle after withholding: 11,400 issued − 5,779 withheld = 5,621 shares.

Key Details

  • Transaction date: 2026-04-01; Form 4 filed: 2026-04-02 (timely).
  • Shares converted (acquired): 11,400 total (1,714; 1,667; 2,660; 5,359). Shares withheld (disposed) for tax: 5,779 at $91.15/share = $526,756.
  • Transaction codes: M = conversion/exercise of derivative (RSU conversion), F = payment of tax liability via share withholding.
  • Footnotes: Company retained shares only to meet the award-holder’s tax withholding obligations and not in excess of the tax liability (F1). The converted shares came from multiple RSU grants with multi-year vesting schedules (grants dated 11/7/2022, 12/13/2023, 11/8/2024, 3/12/2025; see filing footnotes F2–F6).
  • Filing appears timely (transaction date 4/1/2026; filed 4/2/2026).

Context

  • This was vesting/settlement of restricted stock units with a cashless tax-withholding (company retained shares to pay taxes), not an open-market sale or a purchase. Such withholding is routine for RSU vesting and does not necessarily indicate a buy/sell signal about the insider’s market view.

Insider Transaction Report

Form 4
Period: 2026-04-01
Guardant Health, Inc.GH
EAGLE CRAIG
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-04-01+1,714→ 68,094 total
  • Exercise/Conversion

    Common Stock

    2026-04-01+1,667→ 69,761 total
  • Exercise/Conversion

    Common Stock

    2026-04-01+2,660→ 72,421 total
  • Exercise/Conversion

    Common Stock

    2026-04-01+5,359→ 77,780 total
  • Tax Payment

    Common Stock

    [F1]
    2026-04-01$91.15/sh−5,779$526,756→ 72,001 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2][F3]
    2026-04-01−1,714→ 3,429 total
    Exercise: $0.00→ Common Stock (1,714 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F4][F3]
    2026-04-01−1,667→ 3,335 total
    Exercise: $0.00→ Common Stock (1,667 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F5][F3]
    2026-04-01−2,660→ 15,955 total
    Exercise: $0.00→ Common Stock (2,660 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F6][F3]
    2026-04-01−5,359→ 10,883 total
    Exercise: $0.00→ Common Stock (5,359 underlying)
Footnotes (6)
  • [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
  • [F2]This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
  • [F3]Not applicable for Restricted Stock Units.
  • [F4]This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
  • [F5]This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
  • [F6]This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Signature
/s/ John G. Saia, as attorney-in-fact for Craig Eagle|2026-04-02

Documents

1 file
  • 4
    wk-form4_1775164902.xmlPrimary

    FORM 4